Centre for Heart Muscle Disease

2025

Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial.

Lakdawala N., Hershberger R., Garcia-Pavia P., Elliott P., Ginns J., Meder B., Solomon S., Cunningham J., Gimeno J., Barriales-Villa R., Adler E., Gerull B., Pereira N., Halliday B., Li W., Jarugula P., Maruyama S., Mohran S., Papadaki M., Anto A., Anderson R., Rodriguez H., Del Rio C., Edelberg J., Kurio G., Maya J., Januzzi J.

Journal of the American College of Cardiology, 2025

Titin-related familial dilated cardiomyopathy: factors associated with disease onset.

Johnson R., Fletcher R., Peters S., Ohanian M., Soka M., Smolnikov A., Abihider K., Ackerman M., Ader F., Akhtar M., Amin A., Ashley E., Atherton J., Austin R., Baas A., Bagnall R., Ross S., Blouin J., Brown E., Bundgaard H., Cannie D., Chmielewski P., Correnti G., Crespo-Leiro M., Dal Ferro M., Dellefave-Castillo L., Dominguez F., Dooijes D., Dybro A., Ed Demri Y., El Hachmi M., Escobar-Lopez L., Foye S., Franaszczyk M., Gigli M., Lopez E., Goudal A., Graw S., Guipponi M., Haan E., Haas J., Hammersley D., Hansen F., Hayward C., Hey T., Heymans S., Ho C., Houweling A., Ingles J., Ingrey A., Jabbour A., James P., Jansweijer J., Jongbloed J., Keogh A., Larrañaga-Moreira J., Lekanne Deprez R., Macciocca I., Macdonald P., Mansencal N., Mansour J., Martinez-Veira C., McDonough B., McGaughran J., Medo K., Merlo M., Michalak E., Monserrat L., Mountain H., Muller S., Murphy A., Murray B., Oates E., Ormondroyd E., Pachter N., Paldino A., Palmyre A., Pereira N., Picard K., Poplawski N., Prasad S., Proukhnitzky J., Pruny J., Reant P., Richard P., Ronan A., Sedaghat-Hamedani F., Semsarian C., Storm G., Stroeks S., Syrris P., Taylor M., Thomson K., Thompson T., van Tintelen J., Vissing C., Waddell-Smith K., Wallis M., Zentner D., Arnott C., Marian A., Oh J., Fokstuen S., James C., Barriales-Villa R., Meder B., Wahbi K., Giudicessi J., Parikh V., Ware J., Piriou N., Rooryck C., Lakdawala N., Mestroni L., Sinagra G., Elliott P., Watkins H., McNally E., Charron P., van Spaendonck-Zwarts K., Garcia-Pavia P., Peña-Peña M., Mogensen J., Christensen A., Bilińska Z., Rasmussen T., Seidman J., Seidman C., Te Riele A., Verdonschot J., Pinto Y., Christiaans I., Fatkin D.

European heart journal, 2025

Education in cardiovascular genomics and genetics: time for action.

Limongelli G., Arbustini E., Elliott P.

European heart journal, 2025

Childhood-onset RASopathy-associated hypertrophic cardiomyopathy, diastolic dysfunction, and arrhythmias.

Boleti O., Roussos S., Monda E., Norrish G., Field E., Cervi E., Bakalakos A., Fernandes P., McLeod K., Ilina M., Khodaghalian B., Jones C., Escudero F., Castro F., Ali M., Bharucha T., Nepali G., Bhole V., Delle Donne G., Brown E., Gimeno J., Elliott P., Wolf C., Limongelli G., Kaski J.

European heart journal, 2025

Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM.

Hegde S., Wang X., Garcia-Pavia P., Getchevski S., Masri A., Merkely B., Nassif M., Peña-Peña M., Barriales-Villa R., Bilen O., Burroughs M., Claggett B., Costabel J., Correia E., Dybro A., Elliott P., Lakdawala N., Mann A., Maron M., Nair A., Poulsen S., Reant P., Schulze P., Wang A., Sohn R., Berhane I., Heitner S., Jacoby D., Kupfer S., Malik F., Wohltman A., Fifer M., Solomon S.

Journal of the American College of Cardiology, 2025

Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR-CM.

Garcia-Pavia P., Del Moral F., Cappelli F., Piriou N., Barriales-Villa R., Munteanu C., Bahus C., Keohane D., Mallaina P., Itti E., Damy T., Elliott P.

ESC heart failure, 2025

The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy.

Larrañaga-Moreira J., Ochoa J., Peteiro-Debén R., Martín-Álvarez E., Ripoll-Vera T., Álvarez-Rubio J., Peña-Peña M., Llamas-Gómez H., Fernández A., Gallego-Delgado M., Rodríguez-Serrano A., Díez-López C., Elliott P., Palomino-Doza J., Lorca R., Limeres J., Azevedo O., Zorio E., Martín-Dorado E., Méndez-Fernández I., Franco-Gutiérrez R., de Frutos F., Escudero A., Ruiz-Guerrero L., Rodríguez-Vilela A., Mazzanti A., McKenna W., Barriales-Villa R.

JACC. Heart failure, 2025

Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy.

Nassif M., Garcia-Pavia P., Masri A., Merkely B., Peña-Peña M., Barriales-Villa R., Bilen O., Burroughs M., Claggett B., Costabel J., de Barros Correia E., Dybro A., Elliott P., Lakdawala N., Lewis G., Mann A., Maron M., Miao Z., Nair A., Poulsen S., Reant P., Schulze P., Solomon S., Wang A., Sohn R., Berhane I., Heitner S., Jacoby D., Kupfer S., Malik F., Wohltman A., Fifer M., Spertus J.

Journal of the American College of Cardiology, 2025

Aficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial.

Wang A., Garcia-Pavia P., Masri A., Merkely B., Nassif M., Peña-Peña M., Barriales-Villa R., Bilen O., Burroughs M., Claggett B., Costabel J., de Barros Correia E., Dybro A., Elliott P., Hegde S., Kulac I., Lakdawala N., Lewis G., Mann A., Nair A., Poulsen S., Reant P., Schulze P., Solomon S., Sohn R., Berhane I., Heitner S., Jacoby D., Kupfer S., Malik F., Wohltman A., Fifer M., Maron M.

Journal of the American College of Cardiology, 2025

Clinical care of family members of patients with dilated cardiomyopathy.

Verdonschot J., Kaski J., Asselbergs F., Behr E., Charron P., Dawson D., Haugaa K., Kuchynka P., Lopes L., Mazzanti A., Monserrat L., Pantazis A., Prasad S., Schunkert H., Seferovic P., Sheppard M., Sinagra G., van Tintelen J., Tome Esteban M., Heymans S., Garcia-Pavia P.

European heart journal, 2025

Arrhythmogenic cardiomyopathy diagnosis and management: a systematic review of clinical practice guidelines and recommendations with insights for future research.

Iezzi L., Sorella A., Galanti K., Gallina S., Chahal A., Bauce B., Cipriani A., Providencia R., Lopes L., Ricci F., Khanji M.

European heart journal. Quality of care & clinical outcomes, 2025

Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings.

Jurcut R., Barriales-Villa R., Biagini E., Garcia-Pavia P., Olivotto I., Protonotarios A., Arbustini E., Mogensen J., Elliott P., Arbelo E., Kaski J.

European heart journal. Quality of care & clinical outcomes, 2025

Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy.

Desai M., Maurizi N., Biagini E., Charron P., Fernandes F., González-López E., van Haelst P., Haugaa K., Kramer C., Meder B., Michels M., Owens A., Yuasa S., Elliott P.

JACC. Heart failure, 2025

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.

García Hernandez S., de la Higuera Romero L., Fernandez A., Luisa Peña Peña M., Mora-Ayestaran N., Basurte-Elorz M., Larrañaga-Moreira J., Cárdenas Reyes I., Villacorta E., Valverde-Gómez M., Baustista-Paves A., Veira Villanueva E., Ortiz-Genga M., Lipov A., Brogger N., Sabater Molina M., Moreno-Escobar E., Ruiz-Guerrero L., Syrris P., Fernández X., Piqueras-Flores J., Amor Salamanca A., Bezzina C., Elliott P., Barriales-Villa R., Gimeno-Blanes J., García-Pavía P., Walsh R., Ochoa J.

Circulation, 2025

Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.

Gasperetti A., Muller S., Peretto G., Asatryan B., Protonotarios A., Laredo M., Tarlet P., Syrris P., Carrick R., Murray B., Tichnell C., Scheel P., Gigli M., Yap S., Pilichou K., Basso C., Medo K., Jason M., Rossi V., Saguner A., Duru F., Abrams D., Cadrin-Tourigny J., Targetti M., Pieroni M., Graziosi M., Biagini E., Charron P., Cox M., Casella M., Tondo C., Ware J., Prasad S., Calò L., Smith E., Ingles J., Tandri H., Ader F., Peters S., Zentner D., Russo J., Ravaro S., Crotti L., Dittmann S., Schulze-Bahr E., Carruth E., Krysov V., Parikh V., Conte G., Wilde A., van Tintelen J., Te Riele A., Sinagra G., Mestroni L., Taylor M., Merlo M., Adamo L., Calkins H., Bauce B., Arbelo E., Elliott P., Gandjbakhch E., Lakdawala N., Helms A., James C., Gilotra N.

Circulation, 2025

Tailored therapeutics for cardiomyopathies.

Bakalakos A., Monda E., Elliott P.

Nature reviews. Cardiology, 2025

Disease Penetrance in Genotype-Positive But Clinically Unaffected Relatives From Families With Dilated Cardiomyopathy.

Cannie D., Bakalakos A., Syrris P., Protonotarios A., Lorenzini M., Guttmann O., O'Mahony C., Savvatis K., Sekhri N., Mohiddin S., Lopes L., Elliott P.

JACC. Heart failure, 2025

Cardiac magnetic resonance findings in mitochondrial disease: a guide for clinicians.

Gray R., Kantartzı V., Lopes L., Savvatis K., Westwood M.

European heart journal. Imaging methods and practice, 2025

Hypercontractile phenotype in hypertrophic cardiomyopathy indicates unfavorable hemodynamics, coronary flow and prognosis.

Wierzbowska-Drabik K., Pálinkás E., D'Alfonso M., Mori F., Del Franco A., Vazquez J., Re F., Tesic M., Djordjevic-Dikic A., Pálinkás A., Rosa S., Losi M., Rodriguez-Zanella H., Cruz I., Lopes L., Nemes A., Arruda-Olson A., Wang Y., Yin L., Tripepi G., Broncel M., Bartolacelli Y., Pepi M., Carerj S., Ciampi Q., Pellikka P., Olivotto I., Picano E.

European heart journal. Cardiovascular Imaging, 2025

Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.

Masri A., Sherrid M., Choudhury L., Garcia-Pavia P., Kramer C., Barriales-Villa R., Cooper R., Elliott P., Hegde S., Maron M., Nassif M., Oreziak A., Owens A., Solomon S., Tower-Rader A., Heitner S., Jacoby D., Kupfer S., Malik F., Melloni C., Simkins T., Wai J., Saberi S.

Journal of cardiac failure, 2025

Importance of basic science and research training for the future generation of cardiologists.

Chiva-Blanch G., Liehn E., Andreadou I., Barc J., Brundel B., Davidson S., Elliott P., Evans P., Giricz Z., Gladka M., Gollmann-Tepeköylü C., Kleinbongard P., Krieg T., Linde C., Lüscher T., Guzik T., Maguy A., McDonagh T., Paillard M., Parma R., Pesce M., Pompilio G., Rubini M., Streckfuss-Bömeke K., Thielmann M., Tocchetti C., Van Linthout S., Vardas P., Vranckx P., Wojta J., Perrino C.

European heart journal, 2025

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy.

Garcia-Pavia P., Maron M., Masri A., Merkely B., Nassif M., Peña-Peña M., Barriales-Villa R., Bilen O., Burroughs M., Claggett B., Costabel J., Correia E., Dybro A., Elliott P., Hegde S., Lakdawala N., Lewis G., Mann A., Miao Z., Nair A., Poulsen S., Reant P., Schulze P., Solomon S., Wang A., Sohn R., Berhane I., Heitner S., Jacoby D., Kupfer S., Malik F., Wohltman A., Fifer M.

The New England journal of medicine, 2025

Arrhythmic risk stratification in patients with left ventricular ring-like scar.

Parisi V., Graziosi M., Lopes L., De Luca A., Pasquale F., Tini G., Targetti M., Cueto M., Moura A., Ditaranto R., Torlasco C., Taglieri N., Nardi E., Lovato L., Augusto J., Galiè N., Crotti L., Gasperetti A., Biffi M., Autore C., Merlo M., Olivotto I., Sinagra G., Elliott P., Biagini E.

European journal of preventive cardiology, 2025

Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy.

Bhaskaran A., Ben Yaou R., Helms A., Fayssoil A., Richard P., Stojkovic T., Anselme F., Labombarda F., Chikhaoui C., De Sandre-Giovannoli A., Jeru I., Leturcq F., Vigouroux C., Dembele M., Elliott P., Savvatis K., Zeppenfeld K., Bouguerra H., Charron P., Kumar S., Bonne G., Wahbi K., Lakdawala N.

JAMA cardiology, 2025

Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.

Maurizi N., Monda E., Biagini E., Field E., Passantino S., Dall' Aglio G., Fumagalli C., Antiochos P., Skalidis I., Pieroni M., Argirò A., Girolami F., Cecchi F., Barbey F., Monney P., Elliott P., Kaski J., Limongelli G., Olivotto I.

European heart journal, 2025

Cardiomyopathy caused by mitochondrial DNA 4300A > G variant.

Sengupta A., Akhtar M., Akhtar A., Lorenzini M., Slater T., Syrris P., Savvatis K., Bakalakos A., Elliott P.

European heart journal, 2025

Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.

Saberi S., Abraham T., Choudhury L., Barriales-Villa R., Elliott P., Nassif M., Oreziak A., Owens A., Tower-Rader A., Rader F., Garcia-Pavia P., Olivotto I., Coats C., Fifer M., Sherrid M., Solomon S., Watkins H., Heitner S., Jacoby D., Kupfer S., Malik F., Melloni C., Meng L., Wei J., Maron M., Masri A.

JACC. Heart failure, 2025

Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers.

Croon P., van Vugt M., Allaart C., Ruijsink B., Elliott P., Asselbergs F., Khera R., Bezzina C., Winter M., Schmidt A.

BMC medicine, 2025

Rare DCM associated variants in pre-miR-208a disrupt miRNA maturation and function.

Reckman Y., Haas J., van der Made I., Williams S., Diaz I., Akhtar M., Mogensen J., Rasmussen T., Villard E., Charron P., Elliott P., Keavney B., Monserrat L., Pinto Y., Meder B., Tijsen A.

Human molecular genetics, 2025

Myosin inhibitors for treatment of hypertrophic cardiomyopathy.

Quill S., Amin A., Asselbergs F., Bezzina C., Elliott P., van der Velden J., Schmidt A.

The Cochrane database of systematic reviews, 2025

Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.

Smith E., Gasperetti A., Carrick R., Protonotarios A., Syrris P., Bauce B., Pilichou K., Murray B., Tichnell C., Basso C., Olsen P., Cappelletto C., Parikh V., Chen L., Peters S., Mancinelli A., Iorio A., Scotto R., Cadrin-Tourigny J., Gilotra N., Iseppi M., Peretto G., Schiavone M., Abela M., Vargas D., Crescenzi C., Calò L., Ware J., Crotti L., Ciabatti M., Casella M., Apostu A., Jurcut R., Raineri C., Angelini F., Fernández-Sellers C., Zorio E., Yap S., Cox M., Salavati A., Te Riele A., Wilde A., Amin A., van Tintelen P., Saguner A., Duru F., Abrams D., Cerrone M., Graziosi M., Biagini E., Gimeno J., Gandjbakhch E., Lakdawala N., Pieroni M., Merlo M., Sinagra G., Haugaa K., Arbelo E., Elliott P., Taylor M., Mestroni L., Calkins H., James C., Helms A.

medRxiv : the preprint server for health sciences, 2025

NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes.

Tsatsopoulou A., Abrams D., Anastasakis A., Antoniades L., Arbelo E., Arbustini E., Ashley E., Asimaki A., Basso C., Bossone E., Cadrin-Turigny J., Calkins H., Carbone A., Elliott P., Efthimiadis G., Franzese M., Frogoudaki A., Gimeno J., McGrath J., Ingles J., Kaski J., Keren A., Kohiadakis G., Lazarou E., Lazaros G., Lerakis S., Limongelli G., Meditskou S., Mestroni L., Metaxa I., Monda E., Papatheodorou E., Parharidou D., Patrianakos A., Pilichou K., Protonotarios A., Protonotarios I., Rega S., Rigopoulos A., Saffitz J., Syrris P., Taylor M., Peter van Tintelen J., Vlachopoulos C., Xylouri Z., McKenna W.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese, 2025

Translation of genomics into routine cardiological practice: insights from a European Society of Cardiology Cardiovascular Round Table.

Dimmeler S., Ferri L., Nioi P., O'Donnell C., Damy T., Gómez-Outes A., Giacca M., Guo W., Kavousi M., Kupatt C., Landmesser U., Schunkert H., Zouridakis E., Elliott P.

European heart journal, 2025

Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology.

Schunkert H., Di Angelantonio E., Inouye M., Patel R., Ripatti S., Widen E., Sanderson S., Kaski J., McEvoy J., Vardas P., Wood A., Aboyans V., Vassiliou V., Visseren F., Lopes L., Elliott P., Kavousi M.

European heart journal, 2025

Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Masri A., Maron M., Abraham T., Nassif M., Barriales-Villa R., Bilen O., Coats C., Elliott P., Garcia-Pavia P., Massera D., Olivotto I., Oreziak A., Owens A., Saberi S., Solomon S., Tower-Rader A., Heitner S., Jacoby D., Melloni C., Wei J., Sherrid M.

JACC. Heart failure, 2025

Assessment of myocardial work in sarcomere gene mutation carriers, healthy controls and overt nonobstructive hypertrophic cardiomyopathy.

Pires C., Joy G., Triantafyllou M., Monteiro R., Ferreira A., Savvatis K., Lopes L.

Echo research and practice, 2025

Reassessment and reclassification of variants of unknown significance in patients with cardiomyopathy in a specialist department.

Horgan S., Kotwal H., Malan A., Sekhri N., Lopes L.

Journal of medical genetics, 2025

Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis.

Shiwani H., Davies R., Topriceanu C., Ditaranto R., Owens A., Raman B., Augusto J., Hughes R., Torlasco C., Dowsing B., Artico J., Joy G., Miranda I., Witschey W., Rodriguez-Palomares J., Badia-Molins C., Crotti L., Cortina-Borja M., Chuang M., Kwong R., Kramer C., Manning W., Ho C., Kellman P., Hughes A., Biagini E., Mohiddin S., Lopes L., Litt H., Ferrari V., Captur G., Moon J.

Journal of the American College of Cardiology, 2025

Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology.

Mizia-Stec K., Gimeno J., Charron P., Elliott P., Kaski J., Maggioni A., Tendera M., Tavazzi L., Wybraniec M., Laroche C., Caforio A.

Open heart, 2025

The Mechanical and Perfusion Basis of Exercise Limitation in Apical Hypertrophic Cardiomyopathy.

Hughes R., Malcolmson J., Monteiro R., Torlasco C., Davies R., Lopes L., Mohiddin S., Captur G., Moon J., Lloyd G.

JACC. Advances, 2025

Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics.

Garcia-Pavia P., Bilen O., Burroughs M., Costabel J., de Barros Correia E., Dybro A., Elliott P., Lakdawala N., Mann A., Nair A., Nassif M., Poulsen S., Reant P., Schulze P., Wang A., Berhane I., Heitner S., Jacoby D., Kupfer S., Malik F., Meng L., Sohn R., Wohltman A., Fifer M.

JACC. Heart failure, 2025

Naxos Disease and Related Cardio-Cutaneous Syndromes.

Protonotarios A., Asimaki A., Basso C., Xylouri Z., Monda E., Protonotarios I., Crisci G., Abrahms D., Anastasakis A., Antoniades L., Bakalakos A., Carbone A., S Coonar A., Gimeno J., Lazaros G., Lerakis S., Mestroni L., Papadopoulos G., Pecchia L., Prandi F., Syrris P., Cadrin-Turigny J., Vasilakis A., Saffitz J., Gaetano Thiene S., Elliott P., Kaski J., McKenna W., Bossone E., Limongelli G., Tsatsopoulou A.

JACC. Advances, 2025

The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association Class.

Sherrod C., Spertus J., Gosch K., Wang A., Elliott P., Lakdawala N., Reaney M., Zhong Y., Lam J., Wyrwich K., Sauer A.

Journal of cardiac failure, 2025

Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing.

Raffle J., Novo Matos J., Wallace M., Wilkie L., Piercy R., Elliott P., Connolly D., Luis Fuentes V., Psifidi A.

Scientific reports, 2025

Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics.

Elliott P., Schunkert H., Bondue A., Behr E., Carrier L., Van Duijn C., García-Pavía P., van der Harst P., Kavousi M., Loeys B., Rocha Lopes L., Pinto Y., Di Toro A., Thum T., Kääb S., Urtis M., Arbustini E.

European heart journal, 2025

Clinical features and outcomes in carriers of pathogenic desmoplakin variants.

Gasperetti A., Carrick R., Protonotarios A., Murray B., Laredo M., van der Schaaf I., Lekanne R., Syrris P., Cannie D., Tichnell C., Cappelletto C., Gigli M., Medo K., Saguner A., Duru F., Gilotra N., Zimmerman S., Hylind R., Abrams D., Lakdawala N., Cadrin-Tourigny J., Targetti M., Olivotto I., Graziosi M., Cox M., Biagini E., Charron P., Casella M., Tondo C., Yazdani M., Ware J., Prasad S., Calò L., Smith E., Helms A., Hespe S., Ingles J., Tandri H., Ader F., Peretto G., Peters S., Horton A., Yao J., Dittmann S., Schulze-Bahr E., Qureshi M., Young K., Carruth E., Haggerty C., Parikh V., Taylor M., Mestroni L., Wilde A., Sinagra G., Merlo M., Gandjbakhch E., van Tintelen J., Te Riele A., Elliott P., Calkins H., James C.

European heart journal, 2025

Pregnancy in women with dilated cardiomyopathy genetic variants.

Restrepo-Córdoba M., Chmielewski P., Truszkowska G., Peña-Peña M., Kubánek M., Krebsová A., Lopes L., García-Ropero Á., Merlo M., Paldino A., Peters S., Jurcut R., Barriales-Villa R., Zorio E., Hazebroek M., Mogensen J., García-Pavía P.

Revista espanola de cardiologia (English ed.), 2025

State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases.

Van Linthout S., Stellos K., Giacca M., Bertero E., Cannata A., Carrier L., Garcia-Pavia P., Ghigo A., González A., Haugaa K., Imazio M., Lopes L., Most P., Pollesello P., Schunkert H., Streckfuss-Bömeke K., Thum T., Tocchetti C., Tschöpe C., van der Meer P., van Rooij E., Metra M., Rosano G., Heymans S.

European journal of heart failure, 2025

2024

The International Cardiomyopathy Network: a manifesto for change.

Elliott P.

European heart journal, 2024

An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy.

Lopes L., Macken W., Preez S., Kotwal H., Savvatis K., Sekhri N., Mohiddin S., Kabiljo R., Pitceathly R.

Human genomics, 2024

Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy.

Jager J., Ribeiro M., Furtado M., Carvalho T., Syrris P., Lopes L., Elliott P., Cabral J., Carmo-Fonseca M., da Rocha S., Martins S.

Stem cell research, 2024

Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial.

Garcia-Pavia P., Lakdawala N., Sinagra G., Ripoll-Vera T., Afshar K., Priori S., Ware J., Owens A., Li H., Angeli F., Elliott P., MacRae C., Judge D.

ESC heart failure, 2024

Cryo-X-Ray Phase Contrast Imaging Enables Combined 3D Structural Quantification and Nucleic Acid Analysis of Myocardial Biopsies.

Li K., Syrris P., Bonnin A., Treibel T., Budhram-Mahadeo V., Dejea H., Cook A.

Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy.

Garcia-Pavia P., Damy T., Piriou N., Barriales-Villa R., Cappelli F., Bahus C., Munteanu C., Keohane D., Mallaina P., Elliott P.

ESC heart failure, 2024

Impact of Catheter Ablation on Atrial Fibrillation Burden and Symptoms in Patients With Hypertrophic Cardiomyopathy.

Ahluwalia N., Honarbakhsh S., Assadi R., Martin S., Mohiddin S., Elliott P., Creta A., Zeriouh S., Boveda S., Baran J., de Vere F., Rinaldi C., Ding W., Gupta D., El-Nayir M., Ginks M., Ozturk S., Wong T., Procter H., Page S., Lambiase P., Hunter R.

JACC. Clinical electrophysiology, 2024

Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy.

Zheng S., Henry A., Cannie D., Lee M., Miller D., McGurk K., Bond I., Xu X., Issa H., Francis C., De Marvao A., Theotokis P., Buchan R., Speed D., Abner E., Adams L., Aragam K., Ärnlöv J., Raja A., Backman J., Baksi J., Barton P., Biddinger K., Boersma E., Brandimarto J., Brunak S., Bundgaard H., Carey D., Charron P., Cook J., Cook S., Denaxas S., Deleuze J., Doney A., Elliott P., Erikstrup C., Esko T., Farber-Eger E., Finan C., Garnier S., Ghouse J., Giedraitis V., Guðbjartsson D., Haggerty C., Halliday B., Helgadottir A., Hemingway H., Hillege H., Kardys I., Lind L., Lindgren C., Lowery B., Manisty C., Margulies K., Moon J., Mordi I., Morley M., Morris A., Morris A., Morton L., Noursadeghi M., Ostrowski S., Owens A., Palmer C., Pantazis A., Pedersen O., Prasad S., Shekhar A., Smelser D., Srinivasan S., Stefansson K., Sveinbjörnsson G., Syrris P., Tammesoo M., Tayal U., Teder-Laving M., Thorgeirsson G., Thorsteinsdottir U., Tragante V., Trégouët D., Treibel T., Ullum H., Valdes A., van Setten J., van Vugt M., Veluchamy A., Verschuren W., Villard E., Yang Y., Asselbergs F., Cappola T., Dube M., Dunn M., Ellinor P., Hingorani A., Lang C., Samani N., Shah S., Smith J., Vasan R., O'Regan D., Holm H., Noseda M., Wells Q., Ware J., Lumbers R.

Nature genetics, 2024

Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy.

Cabrera-Borrego E., Bermúdez-Jiménez F., Gasperetti A., Tandri H., Sánchez-Millán P., Molina-Lerma M., Roca-Luque I., Vázquez-Calvo S., Compagnucci P., Casella M., Tondo C., Peichl P., Peretto G., Paiotti E., Saguner A., Castro-Urda V., Mora-Ayestarán N., Larrañaga-Moreira J., Fernández de-Aspe P., Barriales-Villa R., Muñoz-Esparza C., Zorio E., Martínez-Solé J., Lopes L., Tonko J., Lambiase P., Elliott P., Rodríguez-Mañero M., Cañadas-Godoy V., Giacoman S., Álvarez-López M., Macías-Ruiz R., McKenna W., Tercedor-Sánchez L., Jiménez-Jáimez J.

Circulation. Arrhythmia and electrophysiology, 2024

Genetic basis of right and left ventricular heart shape.

Burns R., Young W., Aung N., Lopes L., Elliott P., Syrris P., Barriales-Villa R., Sohrabi C., Petersen S., Ramírez J., Young A., Munroe P.

Nature communications, 2024

Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.

Masri A., Choudhury L., Barriales-Villa R., Elliott P., Maron M., Nassif M., Oreziak A., Owens A., Saberi S., Tower-Rader A., Rader F., Garcia-Pavia P., Olivotto I., Nagueh S., Wang A., Heitner S., Jacoby D., Kupfer S., Malik F., Melloni C., Meng L., Wei J., Sherrid M., Abraham T.

Journal of the American College of Cardiology, 2024

Association of Echocardiographic Parameters and Health Status in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From EXPLORER-HCM.

Arnold S., Gosch K., Dolan C., Fine J., Masri A., Saberi S., Wang A., Elliott P., Hegde S., Lam J., Sehnert A., Cresci S., Bach R., Spertus J.

Circulation, 2024

Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population.

Aung N., Nicholls H., Chahal C., Khanji M., Rauseo E., Chadalavada S., Petersen S., Munroe P., Elliott P., Lopes L.

JAMA cardiology, 2024

European Heart Journal: a call to action.

Crea F., Badimon L., Berry C., De Caterina R., Elliott P., Hatala R., Libby P., Linde C., Tybjærg-Hansen A.

European heart journal, 2024

Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients.

Ministrini S., Niederberger R., Akhmedov A., Beer G., Puspitasari Y., Franzini M., Vergaro G., Cannie D., Elliott P., Kahr P., Hock C., Kobza R., Toggweiler S., Lüscher T., Camici G., Stämpfli S.

Vascular pharmacology, 2024

Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: A 36-week analysis from FOREST-HCM.

Masri A., Barriales-Villa R., Elliott P., Nassif M., Oreziak A., Owens A., Tower-Rader A., Heitner S., Kupfer S., Malik F., Melloni C., Meng L., Wei J., Saberi S.

European journal of heart failure, 2024

A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.

Carrick R., Gasperetti A., Protonotarios A., Murray B., Laredo M., van der Schaaf I., Dooijes D., Syrris P., Cannie D., Tichnell C., Gilotra N., Cappelletto C., Medo K., Saguner A., Duru F., Hylind R., Abrams D., Lakdawala N., Cadrin-Tourigny J., Targetti M., Olivotto I., Graziosi M., Cox M., Biagini E., Charron P., Compagnucci P., Casella M., Conte G., Tondo C., Yazdani M., Ware J., Prasad S., Calò L., Smith E., Helms A., Hespe S., Ingles J., Tandri H., Ader F., Peretto G., Peters S., Horton A., Yao J., Schulze-Bahr E., Dittman S., Carruth E., Young K., Qureshi M., Haggerty C., Parikh V., Taylor M., Mestroni L., Wilde A., Sinagra G., Merlo M., Gandjbakhch E., van Tintelen J., Te Riele A., Elliott P., Calkins H., Wu K., James C.

European heart journal, 2024

Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.

Lopes L., Ho C., Elliott P.

European heart journal, 2024

A Proof of Principle 2D Spatial Proteome Mapping Analysis Reveals Distinct Regional Differences in the Cardiac Proteome.

Heywood W., Searle J., Collis R., Doykov I., Ashworth M., Sebire N., Bamber A., Gautel M., Eaton S., Coats C., Elliott P., Mills K.

Life (Basel, Switzerland), 2024

Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.

Caforio A., Kaski J., Gimeno J., Elliott P., Laroche C., Tavazzi L., Tendera M., Fu M., Sala S., Seferovic P., Heliö T., Calò L., Blagova O., Amin A., Kindermann I., Sinagra G., Frustaci A., Bonnet D., Charron P., Maggioni A.

European heart journal, 2024

Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing.

Malcolmson J., Hughes R., Husselbury T., Khan K., Learoyd A., Lees M., Wicks E., Smith J., Simms A., Moon J., Lopes L., O'Mahony C., Sekhri N., Elliott P., Petersen S., Dhinoja M., Mohiddin S.

Circulation. Arrhythmia and electrophysiology, 2024

REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic

Garcia-Pavia P., Palomares J., Sinagra G., Barriales-Villa R., Lakdawala N., Gottlieb R., Goldberg R., Elliott P., Lee P., Li H., Angeli F., Judge D., MacRae C.

Circulation. Heart failure, 2024

A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making.

Green N., Chen Y., O'Mahony C., Elliott P., Barriales-Villa R., Monserrat L., Anastasakis A., Biagini E., Gimeno J., Limongelli G., Pavlou M., Omar R.

European heart journal. Quality of care & clinical outcomes, 2024

Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy.

Bermudez-Jimenez F., Protonotarios A., García-Hernández S., Pérez Asensio A., Rampazzo A., Zorio E., Brodehl A., Arias M., Macías-Ruiz R., Fernández-Armenta J., Remior Perez P., Muñoz-Esparza C., Pilichou K., Bauce B., Merino J., Moliner-Abós C., Ochoa J., Barriales-Villa R., Garcia-Pavia P., Lopes L., Syrris P., Corrado D., Elliott P., McKenna W., Jimenez-Jaimez J.

JACC. Clinical electrophysiology, 2024

Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis: A Systematic Review and Meta-Analysis.

Monda E., Bakalakos A., Cannie D., O'Mahony C., Syrris P., Kaski J., Limongelli G., Elliott P.

JACC. Heart failure, 2024

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease.

Monda E., Bakalakos A., Lachmann R., Syrris P., Limongelli G., Murphy E., Hughes D., Elliott P.

Heart (British Cardiac Society), 2024

The Diagnostic and Therapeutic Implications of Phenocopies and Mimics of Hypertrophic Cardiomyopathy.

Bakalakos A., Monda E., Elliott P.

The Canadian journal of cardiology, 2024

Predicted Deleterious Variants in Cardiomyopathy Genes Prognosticate Mortality and Composite Outcomes in the UK Biobank.

Asatryan B., Shah R., Sharaf Dabbagh G., Landstrom A., Darbar D., Khanji M., Lopes L., van Duijvenboden S., Muser D., Lee A., Haggerty C., Arora P., Semsarian C., Reichlin T., Somers V., Owens A., Petersen S., Deo R., Munroe P., Aung N., Chahal C.

JACC. Heart failure, 2024

Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy.

Hughes R., Shiwani H., Rosmini S., Augusto J., Burke L., Jiang Y., Pierce I., Joy G., Castelletti S., Orini M., Kellman P., Xue H., Lopes L., Mohiddin S., Treibel T., Manisty C., Captur G., Davies R., Moon J.

JACC. Cardiovascular imaging, 2024

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.

Kaski J., Norrish G., Gimeno Blanes J., Charron P., Elliott P., Tavazzi L., Tendera M., Laroche C., Maggioni A., Baban A., Khraiche D., Ziolkowska L., Limongelli G., Ojala T., Gorenflo M., Anastasakis A., Mostafa S., Caforio A.

European heart journal, 2024

Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block.

Cannie D., Patel K., Protonotarios A., Heenan I., Bakalakos A., Syrris P., Menezes L., Elliott P.

Open heart, 2024

Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography.

Joy G., Lopes L., Webber M., Ardissino A., Wilson J., Chan F., Pierce I., Hughes R., Moschonas K., Shiwani H., Jamieson R., Velazquez P., Vijayakumar R., Dall'Armellina E., Macfarlane P., Manisty C., Kellman P., Davies R., Tome M., Koncar V., Tao X., Guger C., Rudy Y., Hughes A., Lambiase P., Moon J., Orini M., Captur G.

Journal of the American College of Cardiology, 2024

Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular Cardiomyopathy.

Gasperetti A., Carrick R., Protonotarios A., Laredo M., van der Schaaf I., Syrris P., Murray B., Tichnell C., Cappelletto C., Gigli M., Medo K., Crabtree P., Saguner A., Duru F., Hylind R., Abrams D., Lakdawala N., Massie C., Cadrin-Tourigny J., Targetti M., Olivotto I., Graziosi M., Cox M., Biagini E., Charron P., Casella M., Tondo C., Yazdani M., Ware J., Prasad S., Calò L., Smith E., Helms A., Hespe S., Ingles J., Tandri H., Ader F., Mestroni L., Wilde A., Merlo M., Gandjbakhch E., Calkins H., Te Riele A., Peter van Tintelen J., Elliot P., James C.

JACC. Advances, 2024

Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.

Elliott P.

European heart journal, 2024

Corrigendum to 'Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management' [International Journal of Cardiology, 2023, 41:180-186].

Brignole M., Cecchi F., Anastasakis A., Crotti L., Deharo J., Elliott P., Fedorowski A., Kaski J., Limongelli G., Maron M., Olivotto I., Ommen S., Parati G., Shen W., Ungar A., Wilde A.

International journal of cardiology, 2024

Reply to 'Effects of tafamidis on heart failure hospitalization: The tale of the dog that did not bark'.

Elliott P., Gundapaneni B., Garcia-Pavia P.

European journal of heart failure, 2024

Management of arrhythmogenic right ventricular cardiomyopathy.

Al-Aidarous S., Protonotarios A., Elliott P., Lambiase P.

Heart (British Cardiac Society), 2024

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial.

Shah S., Fine N., Garcia-Pavia P., Klein A., Fernandes F., Weissman N., Maurer M., Boman K., Gundapaneni B., Sultan M., Elliott P.

JAMA cardiology, 2024

Electrocardiographic abnormalities in patients with cardiomyopathies.

Aimo A., Milandri A., Barison A., Pezzato A., Morfino P., Vergaro G., Merlo M., Argirò A., Olivotto I., Emdin M., Finocchiaro G., Sinagra G., Elliott P., Rapezzi C.

Heart failure reviews, 2024

2023

Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy.

Seitler S., De Zoysa Anthony S., Obianyo C., Syrris P., Patel V., Sado D., Maestrini V., Castelletti S., Walsh S., O'Brien B., Moon J., Captur G.

European heart journal. Cardiovascular Imaging, 2023

Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failure.

Cannie D., Syrris P., Protonotarios A., Bakalakos A., Pruny J., Ditaranto R., Martinez-Veira C., Larrañaga-Moreira J., Medo K., Bermúdez-Jiménez F., Ben Yaou R., Leturcq F., Mezcua A., Marini-Bettolo C., Cabrera E., Reuter C., Limeres Freire J., Rodríguez-Palomares J., Mestroni L., Taylor M., Parikh V., Ashley E., Barriales-Villa R., Jiménez-Jáimez J., Garcia-Pavia P., Charron P., Biagini E., García Pinilla J., Bourke J., Savvatis K., Wahbi K., Elliott P.

European heart journal, 2023

A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients.

Nagyova E., Hoorntje E., Te Rijdt W., Bosman L., Syrris P., Protonotarios A., Elliott P., Tsatsopoulou A., Mestroni L., Taylor M., Sinagra G., Merlo M., Wada Y., Horie M., Mogensen J., Christensen A., Gerull B., Song L., Yao Y., Fan S., Saguner A., Duru F., Koskenvuo J., Cruz Marino T., Tichnell C., Judge D., Dooijes D., Lekanne Deprez R., Basso C., Pilichou K., Bauce B., Wilde A., Charron P., Fressart V., van der Heijden J., van den Berg M., Asselbergs F., James C., Jongbloed J., Harakalova M., van Tintelen J.

Journal of cardiovascular translational research, 2023

Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.

Braunwald E., Saberi S., Abraham T., Elliott P., Olivotto I.

European heart journal, 2023

Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making.

Norrish G., Protonotarios A., Stec M., Boleti O., Field E., Cervi E., Elliott P., Kaski J.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023

Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms.

Elliott P., Gundapaneni B., Sultan M., Ines M., Garcia-Pavia P.

European journal of heart failure, 2023

Detecting transthyretin amyloid cardiomyopathy (ATTR-CM) using machine learning: an evaluation of the performance of an algorithm in a UK setting.

Tsang C., Huda A., Norman M., Dickerson C., Leo V., Brownrigg J., Mamas M., Elliott P.

BMJ open, 2023

Risks of Ventricular Arrhythmia and Heart Failure in Carriers of

Cannie D., Protonotarios A., Bakalakos A., Syrris P., Lorenzini M., De Stavola B., Bjerregaard L., Dybro A., Hey T., Hansen F., Navarro Peñalver M., Crespo-Leiro M., Larrañaga-Moreira J., de Frutos F., Johnson R., Slater T., Monserrat L., Sengupta A., Mestroni L., Taylor M., Sinagra G., Bilinska Z., Solla-Ruiz I., Arana Achaga X., Barriales-Villa R., Garcia-Pavia P., Gimeno J., Dal Ferro M., Merlo M., Wahbi K., Fatkin D., Mogensen J., Rasmussen T., Elliott P.

Circulation. Genomic and precision medicine, 2023

Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.

Joy G., Kelly C., Webber M., Pierce I., Teh I., McGrath L., Velazquez P., Hughes R., Kotwal H., Das A., Chan F., Bakalakos A., Lorenzini M., Savvatis K., Mohiddin S., Macfarlane P., Orini M., Manisty C., Kellman P., Davies R., Lambiase P., Nguyen C., Schneider J., Tome M., Captur G., Dall'Armellina E., Moon J., Lopes L.

Circulation, 2023

Structure determination and analysis of titin A-band fibronectin type III domains provides insights for disease-linked variants and protein oligomerisation.

Rees M., Nikoopour R., Alexandrovich A., Pfuhl M., Lopes L., Akhtar M., Syrris P., Elliott P., Carr-White G., Gautel M.

Journal of structural biology, 2023

Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine.

Monda E., Bakalakos A., Rubino M., Verrillo F., Diana G., De Michele G., Altobelli I., Lioncino M., Perna A., Falco L., Palmiero G., Elliott P., Limongelli G.

Circulation. Heart failure, 2023

Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art Review.

Ostrominski J., Guo R., Elliott P., Ho C.

JACC. Heart failure, 2023

The never-ending hunt for risk predictors in hypertrophic cardiomyopathy: the role of cardiac magnetic resonance tissue characterization.

Bakalakos A., Elliott P.

European heart journal. Cardiovascular Imaging, 2023

Detection of subclinical hypertrophic cardiomyopathy.

Joy G., Moon J., Lopes L.

Nature reviews. Cardiology, 2023

Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?

Lorenzini M., Elliott P.

European heart journal, 2023

Towards a New Classification of Cardiomyopathies.

Elliott P.

Current cardiology reports, 2023

Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial.

Wheeler M., Olivotto I., Elliott P., Saberi S., Owens A., Maurer M., Masri A., Sehnert A., Edelberg J., Chen Y., Florea V., Malhotra R., Wang A., Oreziak A., Myers J.

JAMA cardiology, 2023

Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy.

Hughes R., Augusto J., Knott K., Davies R., Shiwani H., Seraphim A., Malcolmson J., Khoury S., Joy G., Mohiddin S., Lopes L., McKenna W., Kellman P., Xue H., Tome M., Sharma S., Captur G., Moon J.

Circulation. Cardiovascular imaging, 2023

Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy.

Aung N., Lopes L., van Duijvenboden S., Harper A., Goel A., Grace C., Ho C., Weintraub W., Kramer C., Neubauer S., Watkins H., Petersen S., Munroe P.

Circulation. Genomic and precision medicine, 2023

Alpha kinase 3 signaling at the M-band maintains sarcomere integrity and proteostasis in striated muscle.

McNamara J., Parker B., Voges H., Mehdiabadi N., Bolk F., Ahmad F., Chung J., Charitakis N., Molendijk J., Zech A., Lal S., Ramialison M., Karavendzas K., Pointer H., Syrris P., Lopes L., Elliott P., Lynch G., Mills R., Hudson J., Watt K., Porrello E., Elliott D.

Nature cardiovascular research, 2023

Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.

Wheeler M., Jacoby D., Elliott P., Saberi S., Hegde S., Lakdawala N., Myers J., Sehnert A., Edelberg J., Li W., Olivotto I.

European journal of heart failure, 2023

Polygenic risk scores for the prediction of cardiometabolic disease.

O'Sullivan J., Ashley E., Elliott P.

European heart journal, 2023

Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language Summary.

Elliott P., Drachman B., Gottlieb S., Hoffman J., Hummel S., Lenihan D., Ebede B., Gundapaneni B., Li B., Sultan M., Shah S.

Future cardiology, 2023

Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.

Brignole M., Cecchi F., Anastasakis A., Crotti L., Deharo J., Elliott P., Fedorowski A., Kaski J., Limongelli G., Maron M., Olivotto I., Ommen S., Parati G., Shen W., Ungar A., Wilde A.

International journal of cardiology, 2023

Editorial: Comprehensive risk prediction in cardiomyopathies: new genetic and imaging markers of risk, volume II.

Cardim N., Lopes L., Quarta G.

Frontiers in cardiovascular medicine, 2023

The atrial and ventricular myocardial proteome of end-stage lamin heart disease.

Topriceanu C., Alfarih M., Hughes A., Shiwani H., Chan F., Mohiddin S., Moody W., Steeds R., O'Brien B., Vowinckel J., Syrris P., Coats C., Pettit S., Arbustini E., Moon J., Captur G.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2023

2022

Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity.

Fanti S., Stephenson E., Rocha-Vieira E., Protonotarios A., Kanoni S., Shahaj E., Longhi M., Vyas V., Dyer C., Pontarini E., Asimaki A., Bueno-Beti C., De Gaspari M., Rizzo S., Basso C., Bombardieri M., Coe D., Wang G., Harding D., Gallagher I., Solito E., Elliott P., Heymans S., Sikking M., Savvatis K., Mohiddin S., Marelli-Berg F.

Circulation, 2022

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry.

Lopes L., Losi M., Sheikh N., Laroche C., Charron P., Gimeno J., Kaski J., Maggioni A., Tavazzi L., Arbustini E., Brito D., Celutkiene J., Hagege A., Linhart A., Mogensen J., Garcia-Pinilla J., Ripoll-Vera T., Seggewiss H., Villacorta E., Caforio A., Elliott P.

European heart journal. Quality of care & clinical outcomes, 2022

Integrin α7 Mutations Are Associated With Adult-Onset Cardiac Dysfunction in Humans and Mice.

Bugiardini E., Nunes A., Oliveira-Santos A., Dagda M., Fontelonga T., Barraza-Flores P., Pittman A., Morrow J., Parton M., Houlden H., Elliott P., Syrris P., Maas R., Akhtar M., Küsters B., Raaphorst J., Schouten M., Kamsteeg E., van Engelen B., Hanna M., Phadke R., Lopes L., Matthews E., Burkin D.

Journal of the American Heart Association, 2022

Cardiac Outcomes in Adults With Mitochondrial Diseases.

Savvatis K., Vissing C., Klouvi L., Florian A., Rahman M., Béhin A., Fayssoil A., Masingue M., Stojkovic T., Bécane H., Berber N., Mochel F., Duboc D., Fontaine B., Krett B., Stalens C., Lejeune J., Pitceathly R., Lopes L., Saadi M., Gossios T., Procaccio V., Spinazzi M., Tard C., De Groote P., Dhaenens C., Douillard C., Echaniz-Laguna A., Quinlivan R., Hanna M., Yilmaz A., Vissing J., Laforêt P., Elliott P., Wahbi K.

Journal of the American College of Cardiology, 2022

Natural History of MYH7-Related Dilated Cardiomyopathy.

de Frutos F., Ochoa J., Navarro-Peñalver M., Baas A., Bjerre J., Zorio E., Méndez I., Lorca R., Verdonschot J., García-Granja P., Bilinska Z., Fatkin D., Fuentes-Cañamero M., García-Pinilla J., García-Álvarez M., Girolami F., Barriales-Villa R., Díez-López C., Lopes L., Wahbi K., García-Álvarez A., Rodríguez-Sánchez I., Rekondo-Olaetxea J., Rodríguez-Palomares J., Gallego-Delgado M., Meder B., Kubanek M., Hansen F., Restrepo-Córdoba M., Palomino-Doza J., Ruiz-Guerrero L., Sarquella-Brugada G., Perez-Perez A., Bermúdez-Jiménez F., Ripoll-Vera T., Rasmussen T., Jansen M., Sabater-Molina M., Elliot P., Garcia-Pavia P.

Journal of the American College of Cardiology, 2022

Understanding the Prognostic Significance of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy.

Elliott P., Lorenzini M.

JACC. Cardiovascular imaging, 2022

Indications and utility of cardiac genetic testing in athletes.

Castelletti S., Gray B., Basso C., Behr E., Crotti L., Elliott P., Gonzalez Corcia C., D'Ascenzi F., Ingles J., Loeys B., Pantazis A., Pieles G., Saenen J., Sarquella Brugada G., Sanz de la Garza M., Sharma S., Van Craenebroek E., Wilde A., Papadakis M.

European journal of preventive cardiology, 2022

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.

Protonotarios A., Bariani R., Cappelletto C., Pavlou M., García-García A., Cipriani A., Protonotarios I., Rivas A., Wittenberg R., Graziosi M., Xylouri Z., Larrañaga-Moreira J., de Luca A., Celeghin R., Pilichou K., Bakalakos A., Lopes L., Savvatis K., Stolfo D., Dal Ferro M., Merlo M., Basso C., Freire J., Rodriguez-Palomares J., Kubo T., Ripoll-Vera T., Barriales-Villa R., Antoniades L., Mogensen J., Garcia-Pavia P., Wahbi K., Biagini E., Anastasakis A., Tsatsopoulou A., Zorio E., Gimeno J., Garcia-Pinilla J., Syrris P., Sinagra G., Bauce B., Elliott P.

European heart journal, 2022

Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.

Brownrigg J., Leo V., Rose J., Low E., Richards S., Carr-White G., Elliott P.

Heart (British Cardiac Society), 2022

Cardiac myosin binding protein-C variants in paediatric-onset hypertrophic cardiomyopathy: natural history and clinical outcomes.

Field E., Norrish G., Acquaah V., Dady K., Cicerchia M., Ochoa J., Syrris P., McLeod K., McGowan R., Fell H., Lopes L., Cervi E., Kaski J.

Journal of medical genetics, 2022

Early Childhood-Onset Hypertrophic Cardiomyopathy in a Family With an In-Frame

Field E., Lopes L., Dady K., Kaski J.

Circulation. Genomic and precision medicine, 2022

Interpretation of genetic variants depends on a clinically guided integration of phenotype and molecular data.

Arbustini E., Urtis M., Elliott P.

European heart journal, 2022

Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.

Shah R., Asatryan B., Sharaf Dabbagh G., Aung N., Khanji M., Lopes L., van Duijvenboden S., Holmes A., Muser D., Landstrom A., Lee A., Arora P., Semsarian C., Somers V., Owens A., Munroe P., Petersen S., Chahal C.

Circulation, 2022

Response by Elliott et al to Letter Regarding Article, "Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy".

Elliott P., Gundapaneni B., Sultan M.

Circulation. Heart failure, 2022

The European Heart Journal: fulfilling the mission.

Crea F., Badimon L., Berry C., De Caterina R., Elliott P., Hatala R., Libby P., Linde C., Tybjaerg-Hansen A.

European heart journal, 2022

European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary.

Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D., Gale C., Maggioni A., Petersen S., Huculeci R., Kazakiewicz D., Rubio V., Ignatiuk B., Raisi-Estabragh Z., Pawlak A., Karagiannidis E., Treskes R., Gaita D., Beltrame J., McConnachie A., Bardinet I., Graham I., Flather M., Elliott P., Mossialos E., Weidinger F., Achenbach S.

European heart journal. Quality of care & clinical outcomes, 2022

Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.

Norrish G., Cleary A., Field E., Cervi E., Boleti O., Ziółkowska L., Olivotto I., Khraiche D., Limongelli G., Anastasakis A., Weintraub R., Biagini E., Ragni L., Prendiville T., Duignan S., McLeod K., Ilina M., Fernandez A., Marrone C., Bökenkamp R., Baban A., Kubus P., Daubeney P., Sarquella-Brugada G., Cesar S., Klaassen S., Ojala T., Bhole V., Medrano C., Uzun O., Brown E., Gran F., Sinagra G., Castro F., Stuart G., Yamazawa H., Barriales-Villa R., Garcia-Guereta L., Adwani S., Linter K., Bharucha T., Gonzales-Lopez E., Siles A., Rasmussen T., Calcagnino M., Jones C., De Wilde H., Kubo T., Felice T., Popoiu A., Mogensen J., Mathur S., Centeno F., Reinhardt Z., Schouvey S., Elliott P., Kaski J.

Journal of the American College of Cardiology, 2022

Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics.

Arbustini E., Behr E., Carrier L., van Duijn C., Evans P., Favalli V., van der Harst P., Haugaa K., Jondeau G., Kääb S., Kaski J., Kavousi M., Loeys B., Pantazis A., Pinto Y., Schunkert H., Di Toro A., Thum T., Urtis M., Waltenberger J., Elliott P.

European heart journal, 2022

Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases.

Solomon M., Foderà V., Langkilde A., Elliott P., Tagliavini F., Forsyth T., Klementieva O., Bellotti V.

Journal of translational medicine, 2022

Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy.

Moody W., Elliott P.

Heart (British Cardiac Society), 2022

Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.

Norrish G., Ding T., Field E., Cervi E., Ziółkowska L., Olivotto I., Khraiche D., Limongelli G., Anastasakis A., Weintraub R., Biagini E., Ragni L., Prendiville T., Duignan S., McLeod K., Ilina M., Fernández A., Marrone C., Bökenkamp R., Baban A., Kubus P., Daubeney P., Sarquella-Brugada G., Cesar S., Klaassen S., Ojala T., Bhole V., Medrano C., Uzun O., Brown E., Gran F., Sinagra G., Castro F., Stuart G., Vignati G., Yamazawa H., Barriales-Villa R., Garcia-Guereta L., Adwani S., Linter K., Bharucha T., Garcia-Pavia P., Siles A., Rasmussen T., Calcagnino M., Jones C., De Wilde H., Kubo T., Felice T., Popoiu A., Mogensen J., Mathur S., Centeno F., Reinhardt Z., Schouvey S., O'Mahony C., Omar R., Elliott P., Kaski J.

Circulation. Arrhythmia and electrophysiology, 2022

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.

Norrish G., Topriceanu C., Qu C., Field E., Walsh H., Ziółkowska L., Olivotto I., Passantino S., Favilli S., Anastasakis A., Vlagkouli V., Weintraub R., King I., Biagini E., Ragni L., Prendiville T., Duignan S., McLeod K., Ilina M., Fernández A., Bökenkamp R., Baban A., Drago F., Kubuš P., Daubeney P., Chivers S., Sarquella-Brugada G., Cesar S., Marrone C., Medrano C., Alvarez Garcia-Roves R., Uzun O., Gran F., Castro F., Gimeno J., Barriales-Villa R., Rueda F., Adwani S., Searle J., Bharucha T., Siles A., Usano A., Rasmussen T., Jones C., Kubo T., Mogensen J., Reinhardt Z., Cervi E., Elliott P., Omar R., Kaski J.

European journal of preventive cardiology, 2022

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy.

Norrish G., Qu C., Field E., Cervi E., Khraiche D., Klaassen S., Ojala T., Sinagra G., Yamazawa H., Marrone C., Popoiu A., Centeno F., Schouvey S., Olivotto I., Day S., Colan S., Rossano J., Wittekind S., Saberi S., Russell M., Helms A., Ingles J., Semsarian C., Elliott P., Ho C., Omar R., Kaski J.

European journal of preventive cardiology, 2022

Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning.

Davies R., Augusto J., Bhuva A., Xue H., Treibel T., Ye Y., Hughes R., Bai W., Lau C., Shiwani H., Fontana M., Kozor R., Herrey A., Lopes L., Maestrini V., Rosmini S., Petersen S., Kellman P., Rueckert D., Greenwood J., Captur G., Manisty C., Schelbert E., Moon J.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2022

Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant.

Lamounier Junior A., Guitián González A., Rodríguez Vilela A., Repáraz Andrade A., Rubio Alcaide Á., Berta Sousa A., Benito López C., Alonso García D., Fernández Ferro G., Cruz I., Cárdenas Reyes I., Salazar-Mendiguchía García J., Larrañaga-Moreira J., Ochoa J., Palomino-Doza J., de la Higuera Romero L., Nicolás Cicerchia M., Restrepo Córdoba M., Peña-Peña M., Noël Brögger M., Loureiro M., Mogollón Jiménez M., Bilbao Quesada R., Franco Gutiérrez R., García Hernández S., Ripoll-Vera T., Fernández X., Azevedo O., García Pavía P., Lopes L., Ortiz M., Brito D., Barriales-Villa R., Monserrat Iglesias L.

Revista espanola de cardiologia (English ed.), 2022

An overview of heart rhythm disorders and management in myotonic dystrophy type 1.

Gossios T., Providencia R., Creta A., Segal O., Nikolenko N., Turner C., Lopes L., Wahbi K., Savvatis K.

Heart rhythm, 2022

European Society of Cardiology: cardiovascular disease statistics 2021.

Timmis A., Vardas P., Townsend N., Torbica A., Katus H., De Smedt D., Gale C., Maggioni A., Petersen S., Huculeci R., Kazakiewicz D., de Benito Rubio V., Ignatiuk B., Raisi-Estabragh Z., Pawlak A., Karagiannidis E., Treskes R., Gaita D., Beltrame J., McConnachie A., Bardinet I., Graham I., Flather M., Elliott P., Mossialos E., Weidinger F., Achenbach S.

European heart journal, 2022

Phenotyping hypertrophic cardiomyopathy using cardiac diffusion magnetic resonance imaging: the relationship between microvascular dysfunction and microstructural changes.

Das A., Kelly C., Teh I., Nguyen C., Brown L., Chowdhary A., Jex N., Thirunavukarasu S., Sharrack N., Gorecka M., Swoboda P., Greenwood J., Kellman P., Moon J., Davies R., Lopes L., Joy G., Plein S., Schneider J., Dall'Armellina E.

European heart journal. Cardiovascular Imaging, 2022

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy.

Elliott P., Drachman B., Gottlieb S., Hoffman J., Hummel S., Lenihan D., Ebede B., Gundapaneni B., Li B., Sultan M., Shah S.

Circulation. Heart failure, 2022

Editorial: Comprehensive Risk Prediction in Cardiomyopathies: New Genetic and Imaging Markers of Risk.

Lopes L., Quarta G., Cardim N., Gimeno J.

Frontiers in cardiovascular medicine, 2022

2021

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

Hegde S., Lester S., Solomon S., Michels M., Elliott P., Nagueh S., Choudhury L., Zemanek D., Zwas D., Jacoby D., Wang A., Ho C., Li W., Sehnert A., Olivotto I., Abraham T.

Journal of the American College of Cardiology, 2021

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.

Smedley D., Smith K., Martin A., Thomas E., McDonagh E., Cipriani V., Ellingford J., Arno G., Tucci A., Vandrovcova J., Chan G., Williams H., Ratnaike T., Wei W., Stirrups K., Ibanez K., Moutsianas L., Wielscher M., Need A., Barnes M., Vestito L., Buchanan J., Wordsworth S., Ashford S., Rehmström K., Li E., Fuller G., Twiss P., Spasic-Boskovic O., Halsall S., Floto R., Poole K., Wagner A., Mehta S., Gurnell M., Burrows N., James R., Penkett C., Dewhurst E., Gräf S., Mapeta R., Kasanicki M., Haworth A., Savage H., Babcock M., Reese M., Bale M., Baple E., Boustred C., Brittain H., de Burca A., Bleda M., Devereau A., Halai D., Haraldsdottir E., Hyder Z., Kasperaviciute D., Patch C., Polychronopoulos D., Matchan A., Sultana R., Ryten M., Tavares A., Tregidgo C., Turnbull C., Welland M., Wood S., Snow C., Williams E., Leigh S., Foulger R., Daugherty L., Niblock O., Leong I., Wright C., Davies J., Crichton C., Welch J., Woods K., Abulhoul L., Aurora P., Bockenhauer D., Broomfield A., Cleary M., Lam T., Dattani M., Footitt E., Ganesan V., Grunewald S., Compeyrot-Lacassagne S., Muntoni F., Pilkington C., Quinlivan R., Thapar N., Wallis C., Wedderburn L., Worth A., Bueser T., Compton C., Deshpande C., Fassihi H., Haque E., Izatt L., Josifova D., Mohammed S., Robert L., Rose S., Ruddy D., Sarkany R., Say G., Shaw A., Wolejko A., Habib B., Burns G., Hunter S., Grocock R., Humphray S., Robinson P., Haendel M., Simpson M., Banka S., Clayton-Smith J., Douzgou S., Hall G., Thomas H., O'Keefe R., Michaelides M., Moore A., Malka S., Pontikos N., Browning A., Straub V., Gorman G., Horvath R., Quinton R., Schaefer A., Yu-Wai-Man P., Turnbull D., McFarland R., Taylor R., O'Connor E., Yip J., Newland K., Morris H., Polke J., Wood N., Campbell C., Camps C., Gibson K., Koelling N., Lester T., Németh A., Palles C., Patel S., Roy N., Sen A., Taylor J., Cacheiro P., Jacobsen J., Seaby E., Davison V., Chitty L., Douglas A., Naresh K., McMullan D., Ellard S., Temple I., Mumford A., Wilson G., Beales P., Bitner-Glindzicz M., Black G., Bradley J., Brennan P., Burn J., Chinnery P., Elliott P., Flinter F., Houlden H., Irving M., Newman W., Rahman S., Sayer J., Taylor J., Webster A., Wilkie A., Ouwehand W., Raymond F., Chisholm J., Hill S., Bentley D., Scott R., Fowler T., Rendon A., Caulfield M.

The New England journal of medicine, 2021

Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care.

Captur G., Manisty C., Raman B., Marchi A., Wong T., Ariga R., Bhuva A., Ormondroyd E., Lobascio I., Camaioni C., Loizos S., Bonsu-Ofori J., Turer A., Zaha V., Augutsto J., Davies R., Taylor A., Nasis A., Al-Mallah M., Valentin S., Perez de Arenaza D., Patel V., Westwood M., Petersen S., Li C., Tang L., Nakamori S., Nezafat R., Kwong R., Ho C., Fraser A., Watkins H., Elliott P., Neubauer S., Lloyd G., Olivotto I., Nihoyannopoulos P., Moon J.

JACC. Cardiovascular imaging, 2021

Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.

Elliott P.

European heart journal, 2021

The genetic architecture of Plakophilin 2 cardiomyopathy.

Dries A., Kirillova A., Reuter C., Garcia J., Zouk H., Hawley M., Murray B., Tichnell C., Pilichou K., Protonotarios A., Medeiros-Domingo A., Kelly M., Baras A., Ingles J., Semsarian C., Bauce B., Celeghin R., Basso C., Jongbloed J., Nussbaum R., Funke B., Cerrone M., Mestroni L., Taylor M., Sinagra G., Merlo M., Saguner A., Elliott P., Syrris P., van Tintelen J., James C., Haggerty C., Parikh V.

Genetics in medicine : official journal of the American College of Medical Genetics, 2021

Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy.

Dries A., Kirillova A., Reuter C., Garcia J., Zouk H., Hawley M., Murray B., Tichnell C., Pilichou K., Protonotarios A., Medeiros-Domingo A., Kelly M., Baras A., Ingles J., Semsarian C., Bauce B., Celeghin R., Basso C., Jongbloed J., Nussbaum R., Funke B., Cerrone M., Mestroni L., Taylor M., Sinagra G., Merlo M., Saguner A., Elliott P., Syrris P., van Tintelen J., James C., Haggerty C., Parikh V.

Genetics in medicine : official journal of the American College of Medical Genetics, 2021

Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.

Rodrigues T., Raposo S., Brito D., Lopes L.

International journal of cardiology, 2021

Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.

Creta A., Elliott P., Earley M., Dhinoja M., Finlay M., Sporton S., Chow A., Hunter R., Papageorgiou N., Lowe M., Mohiddin S., Boveda S., Adragao P., Jebberi Z., Matos D., Schilling R., Lambiase P., Providência R.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.

Lopes L., Garcia-Hernández S., Lorenzini M., Futema M., Chumakova O., Zateyshchikov D., Isidoro-Garcia M., Villacorta E., Escobar-Lopez L., Garcia-Pavia P., Bilbao R., Dobarro D., Sandin-Fuentes M., Catalli C., Gener Querol B., Mezcua A., Garcia Pinilla J., Bloch Rasmussen T., Ferreira-Aguar A., Revilla-Martí P., Basurte Elorz M., Bautista Paves A., Ramon Gimeno J., Figueroa A., Franco-Gutierrez R., Fuentes-Cañamero M., Martinez Moreno M., Ortiz-Genga M., Piqueras-Flores J., Analia Ramos K., Rudzitis A., Ruiz-Guerrero L., Stein R., Triguero-Bocharán M., de la Higuera L., Ochoa J., Abu-Bonsrah D., Kwok C., Smith J., Porrello E., Akhtar M., Jager J., Ashworth M., Syrris P., Elliott D., Monserrat L., Elliott P.

European heart journal, 2021

Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure.

Akhtar M., Lorenzini M., Pavlou M., Ochoa J., O'Mahony C., Restrepo-Cordoba M., Segura-Rodriguez D., Bermúdez-Jiménez F., Molina P., Cuenca S., Ader F., Larrañaga-Moreira J., Sabater-Molina M., Garcia-Alvarez M., Arantzamendi L., Truszkowska G., Ortiz-Genga M., Ruiz I., Nielsen S., Rasmussen T., Robles Mezcua A., Alvarez-Rubio J., Eiskjaer H., Gautel M., Garcia-Pinilla J., Ripoll-Vera T., Mogensen J., Limeres Freire J., Rodríguez-Palomares J., Peña-Peña M., Rangel-Sousa D., Palomino-Doza J., Arana Achaga X., Bilinska Z., Zamarreño Golvano E., Climent V., Peñalver M., Barriales-Villa R., Charron P., Yotti R., Zorio E., Jiménez-Jáimez J., Garcia-Pavia P., Elliott P.

JAMA cardiology, 2021

A Normal Electrocardiogram Does Not Exclude Infra-Hisian Conduction Disease in Patients With Myotonic Dystrophy Type 1.

Creta A., Providência R., Gossios T., Elliott P., Turner C., Savvatis K., Segal O.

JACC. Clinical electrophysiology, 2021

Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy.

Restrepo-Cordoba M., Wahbi K., Florian A., Jiménez-Jáimez J., Politano L., Arad M., Climent-Paya V., Garcia-Alvarez A., Hansen R., Larrañaga-Moreira J., Kubanek M., Lopes L., Ros A., Jurcut R., Rasmussen T., Ruiz-Guerrero L., Pribe-Wolferts R., Palomino-Doza J., Bilinska Z., Rodríguez-Palomares J., Van Loon R., Basurte Elorz M., Quarta G., Robledo Iñarritu M., Verdonschot J., Stojkovic T., Shomanova Z., Bermudez-Jimenez F., Palladino A., Freimark D., García-Álvarez M., Jorda P., Dominguez F., Ochoa J., Girolami F., Brugada R., Meder B., Barriales-Villa R., Mogensen J., Laforêt P., Yilmaz A., Elliott P., Garcia-Pavia P.

European journal of heart failure, 2021

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.

Jordan E., Peterson L., Ai T., Asatryan B., Bronicki L., Brown E., Celeghin R., Edwards M., Fan J., Ingles J., James C., Jarinova O., Johnson R., Judge D., Lahrouchi N., Lekanne Deprez R., Lumbers R., Mazzarotto F., Medeiros Domingo A., Miller R., Morales A., Murray B., Peters S., Pilichou K., Protonotarios A., Semsarian C., Shah P., Syrris P., Thaxton C., van Tintelen J., Walsh R., Wang J., Ware J., Hershberger R.

Circulation, 2021

Prevalence of Hypertrophic Cardiomyopathy in the UK Biobank Population.

Lopes L., Aung N., van Duijvenboden S., Munroe P., Elliott P., Petersen S.

JAMA cardiology, 2021

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Spertus J., Fine J., Elliott P., Ho C., Olivotto I., Saberi S., Li W., Dolan C., Reaney M., Sehnert A., Jacoby D.

Lancet (London, England), 2021

Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry.

Mizia-Stec K., Charron P., Gimeno Blanes J., Elliott P., Kaski J., Maggioni A., Tavazzi L., Tendera M., Felix S., Dominguez F., Ojrzynska N., Losi M., Limongelli G., Barriales-Villa R., Seferovic P., Biagini E., Wybraniec M., Laroche C., Caforio A.

European heart journal. Cardiovascular Imaging, 2021

Diagnostic Impact of Repeated Expert Review & Long-Term Follow-Up in Determining Etiology of Idiopathic Cardiac Arrest.

Merghani A., Monkhouse C., Kirkby C., Savvatis K., Mohiddin S., Elliott P., O'Mahony C., Lowe M., Schilling R., Lambiase P.

Journal of the American Heart Association, 2021

Iterative Reanalysis of Hypertrophic Cardiomyopathy Exome Data Reveals Causative Pathogenic Mitochondrial DNA Variants.

Lopes L., Murphy D., Bugiardini E., Salem R., Jager J., Futema M., Majid Akhtar M., Savvatis K., Woodward C., Pittman A., Hanna M., Syrris P., Pitceathly R., Elliott P.

Circulation. Genomic and precision medicine, 2021

Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.

Garcia-Pavia P., Bengel F., Brito D., Damy T., Duca F., Dorbala S., Nativi-Nicolau J., Obici L., Rapezzi C., Sekijima Y., Elliott P.

European journal of heart failure, 2021

The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic Cardiomyopathy.

Protonotarios A., Brodehl A., Asimaki A., Jager J., Quinn E., Stanasiuk C., Ratnavadivel S., Futema M., Akhtar M., Gossios T., Ashworth M., Savvatis K., Walhorn V., Anselmetti D., Elliott P., Syrris P., Milting H., Lopes L.

The Canadian journal of cardiology, 2021

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.

James C., Jongbloed J., Hershberger R., Morales A., Judge D., Syrris P., Pilichou K., Domingo A., Murray B., Cadrin-Tourigny J., Lekanne Deprez R., Celeghin R., Protonotarios A., Asatryan B., Brown E., Jordan E., McGlaughon J., Thaxton C., Kurtz C., van Tintelen J.

Circulation. Genomic and precision medicine, 2021

Contemporary and Future Approaches to Precision Medicine in Inherited Cardiomyopathies: JACC Focus Seminar 3/5.

Fatkin D., Calkins H., Elliott P., James C., Peters S., Kovacic J.

Journal of the American College of Cardiology, 2021

Cardiac magnetic resonance assessment of progressive myo-pericarditis due to cobalt cardiotoxicity.

Lorenzini M., Khanji M., Lopes L., Manisty C., Savvatis K.

European heart journal. Cardiovascular Imaging, 2021

Development, validation, and implementation of biomarker testing in cardiovascular medicine state-of-the-art: proceedings of the European Society of Cardiology-Cardiovascular Round Table.

Elliott P., Cowie M., Franke J., Ziegler A., Antoniades C., Bax J., Bucciarelli-Ducci C., Flachskampf F., Hamm C., Jensen M., Katus H., Maisel A., McDonagh T., Mittmann C., Muntendam P., Nagel E., Rosano G., Twerenbold R., Zannad F.

Cardiovascular research, 2021

Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.

Ghidoni A., Elliott P., Syrris P., Calkins H., James C., Judge D., Murray B., Barc J., Probst V., Schott J., Song J., Hauer R., Hoorntje E., van Tintelen J., Schulze-Bahr E., Hamilton R., Mittal K., Semsarian C., Behr E., Ackerman M., Basso C., Parati G., Gentilini D., Kotta M., Mayosi B., Schwartz P., Crotti L.

Circulation. Genomic and precision medicine, 2021

Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy.

Ciampi Q., Olivotto I., Peteiro J., D'Alfonso M., Mori F., Tassetti L., Milazzo A., Monserrat L., Fernandez X., Pálinkás A., Pálinkás E., Sepp R., Re F., Cortigiani L., Tesic M., Djordjevic-Dikic A., Beleslin B., Losi M., Canciello G., Betocchi S., Lopes L., Cruz I., Cotrim C., Torres M., Bellagamba C., Van De Heyning C., Varga A., Ágoston G., Villari B., Lorenzoni V., Carpeggiani C., Picano E., The Stress Echo Study Group On Behalf Of The Italian Society Of Echocardiography And Cardiovascular Imaging Siecvi

Journal of clinical medicine, 2021

Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry.

Gimeno J., Elliott P., Tavazzi L., Tendera M., Kaski J., Laroche C., Barriales-Villa R., Seferovic P., Biagini E., Arbustini E., Lopes L., Linhart A., Mogensen J., Hagege A., Espinosa M., Saad A., Maggioni A., Caforio A., Charron P.

European heart journal. Quality of care & clinical outcomes, 2021

Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.

Pieroni M., Moon J., Arbustini E., Barriales-Villa R., Camporeale A., Vujkovac A., Elliott P., Hagege A., Kuusisto J., Linhart A., Nordbeck P., Olivotto I., Pietilä-Effati P., Namdar M.

Journal of the American College of Cardiology, 2021

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.

Rapezzi C., Elliott P., Damy T., Nativi-Nicolau J., Berk J., Velazquez E., Boman K., Gundapaneni B., Patterson T., Schwartz J., Sultan M., Maurer M.

JACC. Heart failure, 2021

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry.

Asselbergs F., Sammani A., Elliott P., Gimeno J., Tavazzi L., Tendera M., Kaski J., Maggioni A., Rubis P., Jurcut R., Heliö T., Calò L., Sinagra G., Zdravkovic M., Olivotto I., Kavoliūnienė A., Laroche C., Caforio A., Charron P.

ESC heart failure, 2021

Personalized medicine for dilated cardiomyopathy.

Elliott P.

European heart journal, 2021

2020

The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals.

Salazar-Mendiguchía J., Barriales-Villa R., Lopes L., Ochoa J., Rodríguez-Vilela A., Palomino-Doza J., Larrañaga-Moreira J., Cicerchia M., Cárdenas-Reyes I., García-Giustiniani D., Brögger N., Fernández G., García S., Santiago L., Vélez P., Ortiz-Genga M., Elliott P., Monserrat L.

European journal of medical genetics, 2020

Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology.

Mizia-Stec K., Caforio A., Charron P., Gimeno J., Elliott P., Kaski J., Maggioni A., Tavazzi L., Rigopoulos A., Laroche C., Frigy A., Zachara E., Pena-Pena M., Olusegun-Joseph A., Pinto Y., Sala S., Drago F., Blagova O., Reznik E., Tendera M.

ESC heart failure, 2020

The end of the beginning for drug therapy in obstructive hypertrophic cardiomyopathy with EXPLORER-HCM.

Elliott P.

Cardiovascular research, 2020

Dilated cardiomyopathy: so many cardiomyopathies!

Sinagra G., Elliott P., Merlo M.

European heart journal, 2020

Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the

Akhtar M., Lorenzini M., Cicerchia M., Ochoa J., Hey T., Sabater Molina M., Restrepo-Cordoba M., Dal Ferro M., Stolfo D., Johnson R., Larrañaga-Moreira J., Robles-Mezcua A., Rodriguez-Palomares J., Casas G., Peña-Peña M., Lopes L., Gallego-Delgado M., Franaszczyk M., Laucey G., Rangel-Sousa D., Basurte M., Palomino-Doza J., Villacorta E., Bilinska Z., Limeres Freire J., Garcia Pinilla J., Barriales-Villa R., Fatkin D., Sinagra G., Garcia-Pavia P., Gimeno J., Mogensen J., Monserrat L., Elliott P.

Circulation. Heart failure, 2020

ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients.

Heliö T., Elliott P., Koskenvuo J., Gimeno J., Tavazzi L., Tendera M., Kaski J., Mansencal N., Bilińska Z., Carr-White G., Damy T., Frustaci A., Kindermann I., Ripoll-Vera T., Čelutkienė J., Axelsson A., Lorenzini M., Saad A., Maggioni A., Laroche C., Caforio A., Charron P.

ESC heart failure, 2020

State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy.

Patel V., Asatryan B., Siripanthong B., Munroe P., Tiku-Owens A., Lopes L., Khanji M., Protonotarios A., Santangeli P., Muser D., Marchlinski F., Brady P., Chahal C.

International journal of molecular sciences, 2020

Mutations in

Salazar-Mendiguchía J., Ochoa J., Palomino-Doza J., Domínguez F., Díez-López C., Akhtar M., Ramiro-León S., Clemente M., Pérez-Cejas A., Robledo M., Gómez-Díaz I., Peña-Peña M., Climent V., Salmerón-Martínez F., Hernández C., García-Granja P., Mogollón M., Cárdenas-Reyes I., Cicerchia M., García-Giustiniani D., Lamounier A., Gil-Fournier B., Díaz-Flores F., Salguero R., Santomé L., Syrris P., Olivé M., García-Pavía P., Ortiz-Genga M., Elliott P., Monserrat L.

Heart (British Cardiac Society), 2020

The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease.

Crea F., Badimon L., Berry C., De Caterina R., Elliott P., Hatala R., Libby P., Linde C., Tybjærg-Hansen A.

European heart journal, 2020

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.

van der Veen S., Vlietstra W., van Dussen L., van Kuilenburg A., Dijkgraaf M., Lenders M., Brand E., Wanner C., Hughes D., Elliott P., Hollak C., Langeveld M.

International journal of molecular sciences, 2020

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.

Lorenzini M., Norrish G., Field E., Ochoa J., Cicerchia M., Akhtar M., Syrris P., Lopes L., Kaski J., Elliott P.

Journal of the American College of Cardiology, 2020

Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.

Lopez-Sainz A., Dominguez F., Lopes L., Ochoa J., Barriales-Villa R., Climent V., Linschoten M., Tiron C., Chiriatti C., Marques N., Rasmussen T., Espinosa M., Beinart R., Quarta G., Cesar S., Field E., Garcia-Pinilla J., Bilinska Z., Muir A., Roberts A., Santas E., Zorio E., Peña-Peña M., Navarro M., Fernandez A., Palomino-Doza J., Azevedo O., Lorenzini M., García-Álvarez M., Bento D., Jensen M., Méndez I., Pezzoli L., Sarquella-Brugada G., Campuzano O., Gonzalez-Lopez E., Mogensen J., Kaski J., Arad M., Brugada R., Asselbergs F., Monserrat L., Olivotto I., Elliott P., Garcia-Pavia P.

Journal of the American College of Cardiology, 2020

Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy.

Ochoa J., Lopes L., Perez-Barbeito M., Cazón-Varela L., de la Torre-Carpente M., Sonicheva-Paterson N., De Uña-Iglesias D., Quinn E., Kuzmina-Krutetskaya S., Garrote J., Elliott P., Monserrat L.

Clinical genetics, 2020

An expert consensus document on the management of cardiovascular manifestations of Fabry disease.

Linhart A., Germain D., Olivotto I., Akhtar M., Anastasakis A., Hughes D., Namdar M., Pieroni M., Hagège A., Cecchi F., Gimeno J., Limongelli G., Elliott P.

European journal of heart failure, 2020

Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.

Camaioni C., Knott K., Augusto J., Seraphim A., Rosmini S., Ricci F., Boubertakh R., Xue H., Hughes R., Captur G., Lopes L., Brown L., Manisty C., Petersen S., Plein S., Kellman P., Mohiddin S., Moon J.

Heart (British Cardiac Society), 2020

Cryptic Splice-Altering Variants in

Lopes L., Barbosa P., Torrado M., Quinn E., Merino A., Ochoa J., Jager J., Futema M., Carmo-Fonseca M., Monserrat L., Syrris P., Elliott P.

Circulation. Genomic and precision medicine, 2020

DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker.

Scully P., Morris E., Patel K., Treibel T., Burniston M., Klotz E., Newton J., Sabharwal N., Kelion A., Manisty C., Kennon S., Ozkor M., Mullen M., Hartman N., Elliott P., Pugliese F., Hawkins P., Moon J., Menezes L.

JACC. Cardiovascular imaging, 2020

Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype.

Hall C., Akhtar M., Sabater-Molina M., Futema M., Asimaki A., Protonotarios A., Dalageorgou C., Pittman A., Suarez M., Aguilera B., Molina P., Zorio E., Hernández J., Pastor F., Gimeno J., Syrris P., McKenna W.

International journal of cardiology, 2020

Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies With Disease Severity and Family History.

Caforio A., Re F., Avella A., Marcolongo R., Baratta P., Seguso M., Gallo N., Plebani M., Izquierdo-Bajo A., Cheng C., Syrris P., Elliott P., d'Amati G., Thiene G., Basso C., Gregori D., Iliceto S., Zachara E.

Circulation, 2020

Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis.

Corrado D., van Tintelen P., McKenna W., Hauer R., Anastastakis A., Asimaki A., Basso C., Bauce B., Brunckhorst C., Bucciarelli-Ducci C., Duru F., Elliott P., Hamilton R., Haugaa K., James C., Judge D., Link M., Marchlinski F., Mazzanti A., Mestroni L., Pantazis A., Pelliccia A., Marra M., Pilichou K., Platonov P., Protonotarios A., Rampazzo A., Saffitz J., Saguner A., Schmied C., Sharma S., Tandri H., Te Riele A., Thiene G., Tsatsopoulou A., Zareba W., Zorzi A., Wichter T., Marcus F., Calkins H.

European heart journal, 2020

The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy.

James C., Syrris P., van Tintelen J., Calkins H.

European heart journal, 2020

Cardiovascular magnetic resonance imaging volume criteria for arrhythmogenic right ventricular cardiomyopathy: need for update?

Khanji M., Chahal A., Lopes L., Petersen S.

European heart journal, 2020

Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease.

Hu D., Hu D., Liu L., Barr D., Liu Y., Balderrabano-Saucedo N., Wang B., Zhu F., Xue Y., Wu S., Song B., McManus H., Murphy K., Loes K., Adler A., Monserrat L., Antzelevitch C., Gollob M., Elliott P., Barajas-Martinez H.

EBioMedicine, 2020

[A Complicated "One Segment" Myocardial Infarction: The Role of Cardiovascular Imaging].

Pereira A., Almeida A., Cruz I., Lopes L., Loureiro M., Pereira H.

Arquivos brasileiros de cardiologia, 2020

Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.

Augusto J., Eiros R., Nakou E., Moura-Ferreira S., Treibel T., Captur G., Akhtar M., Protonotarios A., Gossios T., Savvatis K., Syrris P., Mohiddin S., Moon J., Elliott P., Lopes L.

European heart journal. Cardiovascular Imaging, 2020

RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.

Hall C., Gurha P., Sabater-Molina M., Asimaki A., Futema M., Lovering R., Suárez M., Aguilera B., Molina P., Zorio E., Coarfa C., Robertson M., Cheedipudi S., Ng K., Delaney P., Hernández J., Pastor F., Gimeno J., McKenna W., Marian A., Syrris P.

International journal of cardiology, 2020

Concerns About the HCM Risk-Kids Study-Reply.

Norrish G., Elliott P., Kaski J.

JAMA cardiology, 2020

A microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy Cohort.

Bueno Marinas M., Celeghin R., Cason M., Bariani R., Frigo A., Jager J., Syrris P., Elliott P., Bauce B., Thiene G., Corrado D., Basso C., Pilichou K.

International journal of molecular sciences, 2020

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?

Protonotarios A., Elliott P.

European cardiology, 2020

New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy.

Maltês S., Lopes L.

Revista portuguesa de cardiologia, 2020

Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population.

Lorenzini M., Anastasiou Z., O'Mahony C., Guttman O., Gimeno J., Monserrat L., Anastasakis A., Rapezzi C., Biagini E., Garcia-Pavia P., Limongelli G., Pavlou M., Elliott P.

JAMA cardiology, 2020

Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning.

Captur G., Heywood W., Coats C., Rosmini S., Patel V., Lopes L., Collis R., Patel N., Syrris P., Bassett P., O'Brien B., Moon J., Elliott P., Mills K.

Molecular & cellular proteomics : MCP, 2020

2019

Prevalence of

Lopes L., Futema M., Akhtar M., Lorenzini M., Pittman A., Syrris P., Elliott P.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2019

Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging.

Donal E., Delgado V., Bucciarelli-Ducci C., Galli E., Haugaa K., Charron P., Voigt J., Cardim N., Masci P., Galderisi M., Gaemperli O., Gimelli A., Pinto Y., Lancellotti P., Habib G., Elliott P., Edvardsen T., Cosyns B., Popescu B.

European heart journal. Cardiovascular Imaging, 2019

Familial cardiomyopathy caused by a novel heterozygous mutation in the gene

Alfarih M., Syrris P., Arbustini E., Augusto J., Hughes A., Lloyd G., Lopes L., Moon J., Mohiddin S., Captur G.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2019

Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts.

Germain D., Falissard B., Hilz M., Spada M., Wanner C., Elliott P.

Molecular genetics and metabolism reports, 2019

Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).

Norrish G., Ding T., Field E., Ziólkowska L., Olivotto I., Limongelli G., Anastasakis A., Weintraub R., Biagini E., Ragni L., Prendiville T., Duignan S., McLeod K., Ilina M., Fernández A., Bökenkamp R., Baban A., Kubuš P., Daubeney P., Sarquella-Brugada G., Cesar S., Marrone C., Bhole V., Medrano C., Uzun O., Brown E., Gran F., Castro F., Stuart G., Vignati G., Barriales-Villa R., Guereta L., Adwani S., Linter K., Bharucha T., Garcia-Pavia P., Rasmussen T., Calcagnino M., Jones C., De Wilde H., Toru-Kubo J., Felice T., Mogensen J., Mathur S., Reinhardt Z., O'Mahony C., Elliott P., Omar R., Kaski J.

JAMA cardiology, 2019

Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Elliott P., Anastasakis A., Asimaki A., Basso C., Bauce B., Brooke M., Calkins H., Corrado D., Duru F., Green K., Judge D., Kelsell D., Lambiase P., McKenna W., Pilichou K., Protonotarios A., Saffitz J., Syrris P., Tandri H., Te Riele A., Thiene G., Tsatsopoulou A., van Tintelen J.

European journal of heart failure, 2019

Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.

Witteles R., Bokhari S., Damy T., Elliott P., Falk R., Fine N., Gospodinova M., Obici L., Rapezzi C., Garcia-Pavia P.

JACC. Heart failure, 2019

Hidden in Heart Failure.

Cannie D., Akhtar M., Elliott P.

European cardiology, 2019

2018

Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.

Coats C., Heywood W., Virasami A., Ashrafi N., Syrris P., Dos Remedios C., Treibel T., Moon J., Lopes L., McGregor C., Ashworth M., Sebire N., McKenna W., Mills K., Elliott P.

Circulation. Genomic and precision medicine, 2018

Frequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation database.

Hall C., Sutanto H., Dalageorgou C., McKenna W., Syrris P., Futema M.

European journal of human genetics : EJHG, 2018

Genetic basis of arrhythmogenic cardiomyopathy.

Karmouch J., Protonotarios A., Syrris P.

Current opinion in cardiology, 2018

Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.

Marian A., Tan Y., Li L., Chang J., Syrris P., Hessabi M., Rahbar M., Willerson J., Cheong B., Liu C., Kleiman N., Bluemke D., Nagueh S.

Circulation research, 2018

Lamin and the heart.

Captur G., Arbustini E., Bonne G., Syrris P., Mills K., Wahbi K., Mohiddin S., McKenna W., Pettit S., Ho C., Muchir A., Gissen P., Elliott P., Moon J.

Heart (British Cardiac Society), 2018

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature.

Captur G., Arbustini E., Syrris P., Radenkovic D., O'Brien B., Mckenna W., Moon J.

Open heart, 2018

No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.

Hoorntje E., Posafalvi A., Syrris P., van der Velde K., Bolling M., Protonotarios A., Boven L., Amat-Codina N., Groeneweg J., Wilde A., Sobreira N., Calkins H., Hauer R., Jonkman M., McKenna W., Elliott P., Sinke R., van den Berg M., Chelko S., James C., van Tintelen J., Judge D., Jongbloed J.

PloS one, 2018

2017

Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.

Castelletti S., Vischer A., Syrris P., Crotti L., Spazzolini C., Ghidoni A., Parati G., Jenkins S., Kotta M., McKenna W., Schwartz P., Pantazis A.

International journal of cardiology, 2017

2016

The structural effects of mutations can aid in differential phenotype prediction of beta-myosin heavy chain (Myosin-7) missense variants.

Al-Numair N., Lopes L., Syrris P., Monserrat L., Elliott P., Martin A.

Bioinformatics (Oxford, England), 2016

Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing.

Nunn L., Lopes L., Syrris P., Murphy C., Plagnol V., Firman E., Dalageorgou C., Zorio E., Domingo D., Murday V., Findlay I., Duncan A., Carr-White G., Robert L., Bueser T., Langman C., Fynn S., Goddard M., White A., Bundgaard H., Ferrero-Miliani L., Wheeldon N., Suvarna S., O'Beirne A., Lowe M., McKenna W., Elliott P., Lambiase P.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016

Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.

Protonotarios A., Anastasakis A., Panagiotakos D., Antoniades L., Syrris P., Vouliotis A., Stefanadis C., Tsatsopoulou A., McKenna W., Protonotarios N.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016

Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy.

Réant P., Hauer A., Castelletti S., Pantazis A., Rosmini S., Cheang M., Peyrou J., Tomé-Esteban M., Syrris P., Lafitte S., Moon J., McKenna W.

The international journal of cardiovascular imaging, 2016

2015

Formation and Malformation of Cardiac Trabeculae: Biological Basis, Clinical Significance, and Special Yield of Magnetic Resonance Imaging in Assessment.

Captur G., Syrris P., Obianyo C., Limongelli G., Moon J.

The Canadian journal of cardiology, 2015

Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy.

Protonotarios A., Anastasakis A., Tsatsopoulou A., Antoniades L., Prappa E., Syrris P., Tousoulis D., McKENNA W., Protonotarios N.

Journal of cardiovascular electrophysiology, 2015

Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.

Reant P., Captur G., Mirabel M., Nasis A., M Sado D., Maestrini V., Castelletti S., Manisty C., Herrey A., Syrris P., Tome-Esteban M., Jenkins S., Elliott P., McKenna W., Moon J.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2015

The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics.

Mogensen J., van Tintelen J., Fokstuen S., Elliott P., van Langen I., Meder B., Richard P., Syrris P., Caforio A., Adler Y., Anastasakis A., Gimeno J., Klingel K., Linhart A., Imazio M., Pinto Y., Newbery R., Schmidtke J., Charron P.

European heart journal, 2015

Atlas of the clinical genetics of human dilated cardiomyopathy.

Haas J., Frese K., Peil B., Kloos W., Keller A., Nietsch R., Feng Z., Müller S., Kayvanpour E., Vogel B., Sedaghat-Hamedani F., Lim W., Zhao X., Fradkin D., Köhler D., Fischer S., Franke J., Marquart S., Barb I., Li D., Amr A., Ehlermann P., Mereles D., Weis T., Hassel S., Kremer A., King V., Wirsz E., Isnard R., Komajda M., Serio A., Grasso M., Syrris P., Wicks E., Plagnol V., Lopes L., Gadgaard T., Eiskjær H., Jørgensen M., Garcia-Giustiniani D., Ortiz-Genga M., Crespo-Leiro M., Deprez R., Christiaans I., van Rijsingen I., Wilde A., Waldenstrom A., Bolognesi M., Bellazzi R., Mörner S., Bermejo J., Monserrat L., Villard E., Mogensen J., Pinto Y., Charron P., Elliott P., Arbustini E., Katus H., Meder B.

European heart journal, 2015

Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.

Lopes L., Syrris P., Guttmann O., O'Mahony C., Tang H., Dalageorgou C., Jenkins S., Hubank M., Monserrat L., McKenna W., Plagnol V., Elliott P.

Heart (British Cardiac Society), 2015

2014

Desmoglein-2 interaction is crucial for cardiomyocyte cohesion and function.

Schlipp A., Schinner C., Spindler V., Vielmuth F., Gehmlich K., Syrris P., Mckenna W., Dendorfer A., Hartlieb E., Waschke J.

Cardiovascular research, 2014

Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression.

Captur G., Lopes L., Patel V., Li C., Bassett P., Syrris P., Sado D., Maestrini V., Mohun T., McKenna W., Muthurangu V., Elliott P., Moon J.

Circulation. Cardiovascular genetics, 2014

Dynamic conduction and repolarisation changes in early arrhythmogenic right ventricular cardiomyopathy versus benign outflow tract ectopy demonstrated by high density mapping & paced surface ECG analysis.

Finlay M., Ahmed A., Sugrue A., Bhar-Amato J., Quarta G., Pantazis A., Ciaccio E., Syrris P., Sen-Chowdhry S., Ben-Simon R., Chow A., Lowe M., Segal O., McKenna W., Lambiase P.

PloS one, 2014

2013

2012

2011

2010

Genetics of Dilated Cardiomyopathy: Risk of Conduction Defects and Sudden Cardiac Death.

Arnous S., Syrris P., Sen-Chowdhry S., McKenna W.

Cardiac electrophysiology clinics, 2010

2009

2008

2007

Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease.

Syrris P., Ward D., Asimaki A., Evans A., Sen-Chowdhry S., Hughes S., McKenna W.

European heart journal, 2007

2006

Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2.

Syrris P., Ward D., Evans A., Asimaki A., Gandjbakhch E., Sen-Chowdhry S., McKenna W.

American journal of human genetics, 2006

Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.

Syrris P., Ward D., Asimaki A., Sen-Chowdhry S., Ebrahim H., Evans A., Hitomi N., Norman M., Pantazis A., Shaw A., Elliott P., McKenna W.

Circulation, 2006